http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#Head http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#assertion http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#provenance http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#pubinfo http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#assertion http://purl.obolibrary.org/obo/DOID_11573 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_11573 http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00199 http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association http://www.w3.org/2000/01/rdf-schema#label to reduce the development of drug resistant bacteria and maintain the effectiveness of ery tab and other antibacterial drugs ery tab should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy r r ery tab tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below r upper respiratory tract infections of mild to moderate degree caused by when used concomitantly with adequate doses of sulfonamides since many strains of are not susceptible to the erythromycin concentrations ordinarily achieved see appropriate sulfonamide labeling for prescribing information streptococcus pyogenes streptococcus pneumoniae haemophilus influenzae h influenzae lower respiratory tract infections of mild to moderate severity caused by or streptococcus pyogenes streptococcus pneumoniae listeriosis caused by listeria monocytogenes respiratory tract infections due to mycoplasma pneumoniae skin and skin structure infections of mild to moderate severity caused by or resistant staphylococci may emerge during treatment streptococcus pyogenes staphylococcus aureus pertussis whooping cough caused by erythromycin is effective in eliminating the organism from the nasopharynx of infected individuals rendering them noninfectious some clinical studies suggest that erythromycin may be helpful in the prophylaxis of pertussis in exposed susceptible individuals bordetella pertussis diphtheria infections due to as an adjunct to antitoxin to prevent establishment of carriers and to eradicate the organism in carriers corynebacterium diphtheriae erythrasma in the treatment of infections due to corynebacterium minutissimum intestinal amebiasis caused by oral erythromycins only extraenteric amebiasis requires treatment with other agents entamoeba histolytica acute pelvic inflammatory disease caused by erythrocin lactobionate i v erythromycin lactobionate for injection usp followed by erythromycin base orally as an alternative drug in treatment of acute pelvic inflammatory disease caused by in female patients with a history of sensitivity to penicillin patients should have a serologic test for syphilis before receiving erythromycin as treatment of gonorrhea and a follow up serologic test for syphilis after 3 months neisseria gonorrhoeae r n gonorrhoeae erythromycins are indicated for treatment of the following infections caused by conjunctivitis of the newborn pneumonia of infancy and urogenital infections during pregnancy when tetracyclines are contraindicated or not tolerated erythromycin is indicated for the treatment of uncomplicated urethral endocervical or rectal infections in adults due to chlamydia trachomatis chlamydia trachomatis when tetracyclines are contraindicated or not tolerated erythromycin is indicated for the treatment of nongonococcal urethritis caused by ureaplasma urealyticum primary syphilis caused by erythromycin oral forms only is an alternative choice of treatment for primary syphilis in patients allergic to the penicillins in treatment of primary syphilis spinal fluid should be examined before treatment and as part of the follow up after therapy treponema pallidum legionnaires disease caused by although no controlled clinical efficacy studies have been conducted and limited preliminary clinical data suggest that erythromycin may be effective in treating legionnaires disease legionella pneumophila in vitro penicillin is considered by the american heart association to be the drug of choice in the prevention of initial attacks of rheumatic fever treatment of streptococcus pyogenes infections of the upper respiratory tract e g tonsillitis or pharyngitis erythromycin is indicated for the treatment of penicillin allergic patients the therapeutic dose should be administered for ten days 4 penicillin or sulfonamides are considered by the american heart association to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever in patients who are allergic to penicillin and sulfonamides oral erythromycin is recommended by the american heart association in the long term prophylaxis of streptococcal pharyngitis for the prevention of recurrent attacks of rheumatic fever 4 http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00199 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#provenance http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#pubinfo http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#sig http://purl.org/nanopub/x/hasSignature K1UIo4MW9K0z/hvsZPmh9fE8nVdhp7LsHFg94f7DZFZckOyDH/7Abx5v7G1LNBPCYQkNDTUrQVDRzwOWqF0/ZnZKiAogDthGKTjyp3Uxbs59IZ3VD0DtryDR0rpf3er5q93Eum+B7M/YvSMQMwST30DVsCCwOurqrcHYrG/Hn0U= http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI http://purl.org/dc/terms/created 2021-06-27T20:36:44.552+02:00 http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAY72KtoVgP1Nf3eMgToQArnVKZxRNO2Y9BRRlLpaACVI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs